MEDICAL IMAGING CENTERS OF AMERICA INC
10-Q, 1995-05-11
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: EXPEDITORS INTERNATIONAL OF WASHINGTON INC, 10-Q, 1995-05-11
Next: OPPENHEIMER NEW YORK TAX EXEMPT FUND, DEFA14A, 1995-05-11



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 10-Q

(Mark One)

/X/      Quarterly Report pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934 For the quarterly period ended March 31, 1995, or

/ /      Transition Report pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934 For the transition period from         to
                                                             -------    -------

                         Commission File Number 0-12787

                    MEDICAL IMAGING CENTERS OF AMERICA, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

          California                                          95-3643045
- - -------------------------------                          ----------------------
(State or other jurisdiction of                            (I.R.S. Employer
incorporation or organization)                           Identification Number)

  9444 Farnham St., Suite 100
  San Diego, California                                           92123
- - ----------------------------------------                        ----------
(Address of principal executive offices)                        (Zip Code)

                                 (619) 560-0110
              ----------------------------------------------------
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                                 Yes  X  No 
                                     ---    ---

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date:

               12,136,560 shares of Common Stock as of May 5, 1995


                                  PAGE 1 OF 8

<PAGE>   2

PART I. FINANCIAL INFORMATION

Item 1.  Financial Statements 

                    MEDICAL IMAGING CENTERS OF AMERICA, INC.
                           CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>
                                                                               March 31, 1995      December 31, 
(in thousands except share information)                                         (Unaudited)            1994 
- - ---------------------------------------                                        --------------      ------------
<S>                                                                              <C>                <C>     
ASSETS:
Current assets:
  Cash and cash equivalents (includes restricted cash of $643 in
     1995 and $832 in 1994)                                                      $  8,161           $  8,524
  Trade and notes receivable, net of allowance for doubtful accounts
     of $5,486 in 1995 and $5,554 in 1994                                           9,154              9,524
  Prepaid expenses and other current assets                                         1,467              1,611
                                                                                 --------           --------

    Total current assets                                                           18,782             19,659

Equipment and leasehold improvements, net of accumulated
    depreciation and amortization of $32,979 in 1995 and
    $33,674 in 1994                                                                24,576             28,813
Equipment held for sale, net of accumulated depreciation
    of $2,461 in 1995 and $1,137 in 1994                                              600                400
Investment in and advances to unconsolidated entities, net of allowance
   for doubtful accounts of $1,788 in 1995 and 1994                                 1,752              2,069
Intangible assets, net of accumulated amortization of
    $1,755 in 1995 and $1,606 in 1994                                               1,129              1,269
Other assets                                                                        1,219              1,259
                                                                                 --------           --------

                                                                                 $ 48,058           $ 53,469
                                                                                 ========           ========

LIABILITIES AND NET CAPITAL DEFICIENCY:
Current liabilities:
  Current portion long-term debt and capital lease obligations                   $ 11,044           $ 11,541
  Current portion convertible subordinated debt                                     2,800              2,800
  Accounts payable                                                                  1,957              2,062
  Accrued payroll and related taxes                                                   791              1,493
  Other accrued liabilities                                                         2,575              3,230
                                                                                 --------           --------

    Total current liabilities                                                      19,167             21,126

Long-term debt and capital lease obligations                                       21,311             25,406
Minority interest in consolidated partnerships                                      1,317              1,598
Convertible subordinated debt                                                       8,200              8,200
Commitments
Net Capital Deficiency:
  Preferred stock, no par value, 5,000,000 shares authorized;
      Series B preferred shares, no par value, 300,000 shares
      authorized, no shares issued or outstanding                                    --                 --   
  Common stock, no par value, 30,000,000 shares authorized;
    12,136,560 and 12,133,227 shares issued and outstanding at
    March 31, 1995 and December 31, 1994, respectively                             54,473             54,473

  Accumulated deficit                                                             (56,410)           (57,334)
                                                                                 --------           --------

      Total Net Capital Deficiency                                                 (1,937)            (2,861)
                                                                                 --------           --------

                                                                                 $ 48,058           $ 53,469
                                                                                 ========           ========
</TABLE>

See accompanying notes. 

                                  PAGE 2 OF 8

<PAGE>   3

                    MEDICAL IMAGING CENTERS OF AMERICA, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS



<TABLE>
<CAPTION>
                                                                 (Unaudited) 
                                                         Three Months Ended March 31, 
(in thousands except per share information)                1995               1994 
- - -------------------------------------------              --------           --------
<S>                                                      <C>                <C>     
REVENUES:
Medical services                                         $ 12,139           $ 14,157
Equipment and medical suite sales                           2,036                235
                                                         --------           --------

    Total revenues                                         14,175             14,392

COSTS AND EXPENSES:
Costs of medical services                                   7,673              9,367
Costs of equipment and medical suite sales                  1,542                213
Marketing, general and administrative                         783              1,149
Depreciation and amortization of equipment
   and leasehold improvements                               2,633              3,048
Amortization of intangibles and deferred costs                158                 93
Equity in net income of unconsolidated entities              (183)              (127)
Interest expense                                              919              1,375
Interest income                                              (154)               (85)
                                                         --------           --------

    Total costs and expenses                               13,371             15,033
                                                         --------           --------

Income (loss) before minority interest                        804               (641)
Minority interest in net (income) loss of
  consolidated partnerships                                   120                (21)
                                                         --------           --------

Net income (loss)                                        $    924           $   (662)
                                                         ========           ======== 


NET INCOME (LOSS) PER SHARE                              $    .07           $   (.05)
                                                         ========           ======== 


SHARES USED IN PER SHARE AMOUNTS                           12,382             12,123
                                                         ========           ======== 
</TABLE>




See accompanying notes. 



                                  PAGE 3 OF 8

<PAGE>   4

                    MEDICAL IMAGING CENTERS OF AMERICA, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS


<TABLE>
<CAPTION>
                                                                                        (Unaudited) 
                                                                                Three Months Ended March 31, 
                                                                                ----------------------------
(in thousands)                                                                     1995              1994 
- - --------------                                                                   -------           -------
<S>                                                                              <C>               <C>     
OPERATING ACTIVITIES:
Net income (loss)                                                                $   924           ($  662)
Adjustments to reconcile net income (loss) to net cash
  provided by operating activities:
   Depreciation and amortization                                                   2,791             3,141
   Provision for bad debts                                                           268               402
   Equity in net income of unconsolidated entities                                  (183)             (127)
   Minority interest in net income (loss) of consolidated partnerships              (120)               21
   Net value of equipment dispositions                                             1,555               227
Change in assets and liabilities
   Decrease in trade receivables                                                      27                59
   Decrease in prepaid expenses and other current assets                             133               278
  (Decrease) increase in accounts payable and other accrued liabilities             (702)               30
   Decrease in accrued payroll and related taxes                                    (701)             (222)
                                                                                 -------           -------

    Net cash provided in operating activities                                      3,992             3,147

INVESTING ACTIVITIES:
Capital expenditures                                                                (169)             (461)
Cost of acquisitions, net of cash acquired                                           (50)             --   
Investment in and advances to unconsolidated entities, net                           520               212
Other, net                                                                             3                (4)
                                                                                 -------           -------

    Net cash used in investing activities                                            304              (253)

FINANCING ACTIVITIES:
Principal payments on long-term debt and capital
  lease obligations                                                               (4,506)           (2,885)
Distribution to minority interests                                                  (151)             (317)
Other, net                                                                            (2)              (56)
                                                                                 -------           -------

    Net cash used in financing activities                                         (4,659)           (3,258)
                                                                                 -------           -------

Net decrease in cash and cash equivalents                                           (363)             (364)
Cash and cash equivalents at beginning of period                                   8,524             8,182
                                                                                 -------           -------

Cash and cash equivalents at end of period                                       $ 8,161           $ 7,818
                                                                                 =======           =======

SUPPLEMENTAL CASH FLOW DATA:

   Interest paid                                                                 $   754           $ 1,210
                                                                                 =======           =======

   Income taxes paid                                                             $     6           $    11
                                                                                 =======           =======

SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:

   Additions to capital lease and long-term debt obligations                     $   280           $ 1,754
                                                                                 =======           =======

   Retirement of debt and termination of capital lease obligations               $   389           $   ---
                                                                                 =======           =======
</TABLE>


See accompanying notes. 




                                  PAGE 4 OF 8

<PAGE>   5

                    MEDICAL IMAGING CENTERS OF AMERICA, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. The financial statements included herein have been prepared by the Company,
without audit, according to the rules and regulations of the Securities and
Exchange Commission. Certain information and footnote disclosures normally
included in financial statements prepared in accordance with generally accepted
accounting principles have been condensed or omitted pursuant to such rules and
regulations, although the Company believes the disclosures that are made are
adequate to make the information presented not misleading. Further, the
financial statements reflect, in the opinion of management, all adjustments
necessary to state fairly the financial position and results of operations as of
and for the periods indicated.

It is suggested that these financial statements be read in conjunction with the
audited financial statements and the notes thereto for the year ended December
31, 1994, which are included in the Company's Form 10-K. The results of
operations for the three months ended March 31, 1995 are not necessarily
indicative of results to be expected for the full fiscal year ending December
31, 1995.

2. Primary net income (loss) per share is computed on the basis of weighted
average number of common shares outstanding and includes common stock
equivalents when their effect is dilutive. For the quarter ended March 31, 1994,
common stock equivalents were excluded from the net loss computation as their
effect was antidilutive.

3. No income tax provisions have been recorded for the three months ended March
31, 1995 and 1994 due to net operating loss carryforwards available for income
tax purposes.

4. Certain 1994 amounts have been reclassified to conform with the March 31,
1995 presentation.


                                  PAGE 5 OF 8

<PAGE>   6



Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations:

BUSINESS Medical Imaging Centers of America, Inc. ("MICA" or the "Company") is a
California corporation organized in July 1981 which provides outpatient services
and medical equipment rentals to physicians, managed care providers and
hospitals. These services include magnetic resonance imaging ("MRI"), computed
tomography ("CT"), nuclear medicine and ultrasound. The Company's operations
include diagnostic medical centers ("DMC's"), diagnostic equipment rentals,
fee-for-service agreements (fixed and mobile), and management, marketing and
related support services.

RESULTS OF OPERATIONS

REVENUES FROM MEDICAL SERVICES Revenues for the first quarter declined from
$14.2 million in 1994 to $12.2 million in 1995, primarily due to the Company's
sale of underperforming assets and termination of certain unprofitable leases
and contracts used in its fee-for-service business. As noted above, a number of
factors exist that could have an impact on the Company's future revenues,
including declining prices and an oversupply in the diagnostic equipment market,
declining trends in reimbursement and competition in the healthcare industry.

REVENUES FROM EQUIPMENT AND MEDICAL SUITE SALES Revenues from equipment and
medical suite sales for the first quarter increased from $.2 million in 1994 to
$2 million in 1995. The increase in sales is due to the quantity and type of
equipment and medical suites sold and will vary accordingly. The Company intends
to sell equipment and its remaining inventory of medical suites in the future,
but such sales are subject to market conditions and there can be no assurances
that such sales will or will not occur.

COSTS OF MEDICAL SERVICES Costs for the first quarter decreased from $9.4
million (66% of medical services revenues) in 1994 to $7.7 million (63% of
medical services revenues) in 1995, primarily due to the Company's sales of
underperforming assets and termination of certain unprofitable leases and
contracts used in its fee-for-service business.

COSTS OF EQUIPMENT AND MEDICAL SUITE SALES Costs of equipment and medical suite
sales for the first quarter increased from $.2 million in 1994 to $1.5 million
in 1995. The difference in costs is directly related to the quantity and type of
equipment and medical suites sold and will vary accordingly.

MARKETING, GENERAL AND ADMINISTRATIVE EXPENSES Marketing, general and
administrative expenses for the first quarter decreased from $1.1 million (8% of
medical services revenues) in 1994 to $.8 million (6% of medical services
revenues) in 1995. The decrease in costs resulted from reductions in the number
of administrative employees and other spending reductions which took place
throughout 1994.

DEPRECIATION AND AMORTIZATION Depreciation and amortization of equipment and
leasehold improvements for the first quarter decreased from $3.1 million in 1994
to $2.8 million in 1995. This decrease is primarily due to the sale of
underperforming assets and termination of certain unprofitable leases used in
the fee-for-service business.

INTEREST EXPENSE Interest expense for the first quarter decreased from $1.4
million in 1994 to $.9 million in 1995. This decrease resulted from the sale of
underperforming assets and termination of certain unprofitable leases used in
the fee-for-service business.


                                  PAGE 6 OF 8

<PAGE>   7

LIQUIDITY AND CAPITAL RESOURCES

At March 31, 1995, the Company's cash and cash equivalents totalled $8.2
million; however, the Company had a working capital deficit of $.4 million. The
working capital deficit reflects the short-term classification of a $2.8 million
mandatory redemption payment made in April towards the Company's convertible
subordinated debt. During the first quarter of 1995, cash flows from operations
of $4 million were offset by payments against long-term debt of $4.5 million.

The Company's ability to meet its current obligations is dependent on its
ability to maintain revenues from existing contracts while reducing related
costs. In addition, a number of factors exist that could have an impact on the
Company's future revenues: (i) declining prices and an oversupply in the
diagnostic equipment market; (ii) changes in healthcare legislation which has
limited reimbursement and prohibited referrals from physician investors; (iii)
healthcare initiatives which could reduce reimbursement to the Company; and (iv)
competition in the healthcare industry.

OPERATING TRENDS

Declining reimbursement continues to adversely impact revenues earned by the
Company, and MICA does not expect improvements in reimbursement trends in the
future. The Company's strategy is to offset the declining trends in
reimbursement by securing managed care contracts and developing strategic
alliances with hospitals or other healthcare providers to increase the extent of
its imaging services. By positioning itself to take advantage of managed care
contracts, management believes that it can maintain its DMC revenues. The
Company will continue to pursue opportunities in its fee-for-service business;
however, the Company expects to sell equipment as contracts expire.

The Company will continue to evaluate its operating costs and reduce spending as
appropriate; however, there can be no assurances that such actions will be
sufficient to provide adequate cash to sustain the operations of the Company.

                           PART II. OTHER INFORMATION

Item 6.     Exhibits and Reports on Form 8-K:

            (a)  Exhibits:

                 None

            (b)  Reports:

                 None


                                  PAGE 7 OF 8

<PAGE>   8





                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                  MEDICAL IMAGING CENTERS OF AMERICA, INC.

Date : May 10, 1995                      /s/ Robert S. Muehlberg
                                         -------------------------------------
                                         Robert S. Muehlberg
                                         Chairman of the Board of Directors,
                                         President and Chief Executive Officer




Date : May 10, 1995                      /s/ Denise L. Sunseri
                                         -------------------------------------
                                         Denise L. Sunseri
                                         Vice President and
                                         Chief Financial Officer


                                  PAGE 8 OF 8

<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1995
<PERIOD-END>                               MAR-31-1995
<EXCHANGE-RATE>                                      1
<CASH>                                           8,161
<SECURITIES>                                         0
<RECEIVABLES>                                   14,640
<ALLOWANCES>                                     5,486
<INVENTORY>                                          0
<CURRENT-ASSETS>                                18,782
<PP&E>                                          60,616
<DEPRECIATION>                                  35,440
<TOTAL-ASSETS>                                  48,058
<CURRENT-LIABILITIES>                           19,167
<BONDS>                                         29,511
<COMMON>                                        54,473
                                0
                                          0
<OTHER-SE>                                    (56,410)
<TOTAL-LIABILITY-AND-EQUITY>                    48,058
<SALES>                                          2,036
<TOTAL-REVENUES>                                14,175
<CGS>                                            1,542
<TOTAL-COSTS>                                    8,947
<OTHER-EXPENSES>                                 2,791
<LOSS-PROVISION>                                   268
<INTEREST-EXPENSE>                                 919
<INCOME-PRETAX>                                    804
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                924
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       924
<EPS-PRIMARY>                                      .07
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission